Cargando…

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge

Detalles Bibliográficos
Autores principales:	Linz, Dominik, Linz, Benedikt, Dobrev, Dobromir, Baumert, Mathias, Hendriks, Jeroen M., Pepin, Jean-Louis, Jespersen, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327655/ https://www.ncbi.nlm.nih.gov/pubmed/34377764 http://dx.doi.org/10.1016/j.ijcha.2021.100843

Ejemplares similares

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Central sleep apnea in atrial fibrillation: Risk factor or marker of untreated underlying disease?
por: Linz, Dominik, et al.
Publicado: (2020)

Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring
por: Linz, Dominik, et al.
Publicado: (2019)

Obstructive Sleep Apnea and Atrial Arrhythmogenesis
por: Hohl, Mathias, et al.
Publicado: (2014)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Sleeping Beauty unravelled – Detection of sleep apnoea in patients with atrial fibrillation
por: Hendriks, Jeroen M., et al.
Publicado: (2023)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Screening for obstructive sleep apnoea in patients with atrial fibrillation: Much more than a screening tool alone
por: Hendriks, Jeroen M., et al.
Publicado: (2020)

Recent highlights on the prevalence and role of sleep disordered breathing in cardiovascular diseases from the International Journal of Cardiology Heart & Vasculature
por: Linz, Dominik, et al.
Publicado: (2023)

Sleep apnea in atrial fibrillation – Highly prevalent, highly relevant, but most patients are not somnolent!
por: Kadhim, Kadhim, et al.
Publicado: (2020)

Undiagnosed sleep apnea in patients with atrial fibrillation: An underutilized opportunity for antiarrhythmic management
por: Hereijgers, Maartje J.M., et al.
Publicado: (2022)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs?
por: Linz, Dominik, et al.
Publicado: (2018)

Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea
por: Baumert, Mathias, et al.
Publicado: (2023)

A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic
por: Linz, Dominik, et al.
Publicado: (2021)

Artificial intelligence for the detection, prediction, and management of atrial fibrillation
por: Isaksen, Jonas L., et al.
Publicado: (2022)

Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously hypertensive rats
por: Linz, Benedikt, et al.
Publicado: (2020)

Does weight matter in cryoballoon ablation?
por: Gawałko, Monika, et al.
Publicado: (2023)

Modeling sleep-disordered breathing using overnight polysomnography—opportunities for patient-oriented research and patient care
por: Baumert, Mathias, et al.
Publicado: (2022)

Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach
por: van der Velden, Rachel M.J., et al.
Publicado: (2022)

Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats
por: Hohl, Mathias, et al.
Publicado: (2017)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Pharmacological inhibition of acetylcholine-regulated potassium current (I(K,ACh)) prevents atrial arrhythmogenic changes in a rat model of repetitive obstructive respiratory events
por: Linz, Benedikt, et al.
Publicado: (2021)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

The impact of Twitter promotion on future citation rates: The #TweetTheJournal study
por: Betz, Konstanze, et al.
Publicado: (2021)

Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept
por: Linz, Benedikt, et al.
Publicado: (2020)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Obstructive sleep apnea and atrial fibrillation
por: Todd, Keith, et al.
Publicado: (2010)

Obstructive Sleep Apnea and Atrial Fibrillation
por: Moula, Amalia Ioanna, et al.
Publicado: (2022)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Researchers in cardiology – Why and how to get on Twitter?
por: Benjamin Fyenbo, Daniel, et al.
Publicado: (2022)

Sleep Arousal-Related Ventricular Repolarization Lability Is Associated With Cardiovascular Mortality in Older Community-Dwelling Men
por: Shahrbabaki, Sobhan Salari, et al.
Publicado: (2023)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_not9aco93thv55e1htq3v461e0